IL-21 antibody (Intermediate Domain)
Quick Overview for IL-21 antibody (Intermediate Domain) (ABIN499986)
Target
See all IL-21 (IL21) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Intermediate Domain
-
Specificity
- IL-21 antibody was raised against a synthetic peptide corresponding to 15 amino acids near the center of human IL-21 precursor.
-
Purification
- Affinity chromatography purified via peptide column
-
Immunogen
- Human IL-21 (Intermediate Domain) Peptide
-
Isotype
- IgG
-
-
-
-
Application Notes
-
ELISA. Western Blot: 0.5 to 1 μg/mL. An approximately 18 kDa band can be detected. Immunocytochemistry.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Buffer
- PBS containing 0.02 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
-
- IL-21 (IL21) (Interleukin 21 (IL21))
-
Alternative Name
- Interleukin-21 / IL21
-
Background
- A novel cytokine was recently identified in human and mouse and designated IL-21 , which has significant homology to IL-2, IL-4, and IL-15. The receptor for IL-21 (IL-21R, also termed NILR for novel Interleukin receptor) is a new member of the class I cytokine receptor family (1,2). IL-21R forms a complex with the common cytokine receptor g chain, gc, and mediates IL-21 signaling (3,4). IL-21 and its receptor activate JAK-STAT signaling pathway. IL-21 is expressed in activated T cells, and HL-60 and THP-1 cell lines. IL-21 plays a role in the proliferation and maturation of NK, B and T cell populations.Synonyms: IL-21, Za11
-
Gene ID
- 59067
-
NCBI Accession
- NP_068575
-
UniProt
- Q9HBE4
-
Pathways
- JAK-STAT Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response
Target
-